Telemedicine in Neurosurgery During the COVID-19 Outbreak: Where We Are 1 Year Later.
COVID-19
Neurosurgery
Telemedicine
Journal
World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
28
12
2021
revised:
09
03
2022
accepted:
10
03
2022
pubmed:
21
3
2022
medline:
24
6
2022
entrez:
20
3
2022
Statut:
ppublish
Résumé
Telemedicine use skyrocketed in March 2020 on implementation of shelter-in-place measures owing to the coronavirus disease 2019 (COVID-19) pandemic. Within the past year, shelter-in-place measures were lifted and the COVID-19 vaccine was released, resulting in many neurosurgeons returning to in-person outpatient clinics. This study aimed to determine the extent of usage of telemedicine in neurosurgery 1 year into the COVID-19 pandemic. A retrospective cohort study of patients who received neurosurgical care at a single institution from February 1 to April 18 of the years 2020 and 2021 was performed. The inclusion criteria were met by 11,592 patients. During the 2 study periods, 1465 patients underwent surgery, 7083 were seen in clinic via an in-person meeting, and 3044 were assessed via telemedicine. At 1 year after the COVID-19 outbreak, telemedicine usage was at 81.3% of the initial volume on implementation of shelter-in-place measures. In-person outpatient visits increased 40.2% from the early pandemic volume. Among the 4 neurosurgery divisions, telemedicine usage remained high in tumor and functional neurosurgery, significantly increased in vascular neurosurgery, and decreased in spine neurosurgery. Telemedicine use in neurosurgery clinics continues 1 year after the COVID-19 outbreak. Even after the lifting of shelter-in-place measures, many neurosurgeons still use telemedicine, while the operative volume remains stable. Owing to the limited physical examination that can be performed via current telemedicine platforms, telemedicine use in spine neurosurgery is lower than peak use during the early pandemic, while use has remained high among tumor, vascular, and functional neurosurgery.
Sections du résumé
BACKGROUND
Telemedicine use skyrocketed in March 2020 on implementation of shelter-in-place measures owing to the coronavirus disease 2019 (COVID-19) pandemic. Within the past year, shelter-in-place measures were lifted and the COVID-19 vaccine was released, resulting in many neurosurgeons returning to in-person outpatient clinics. This study aimed to determine the extent of usage of telemedicine in neurosurgery 1 year into the COVID-19 pandemic.
METHODS
A retrospective cohort study of patients who received neurosurgical care at a single institution from February 1 to April 18 of the years 2020 and 2021 was performed. The inclusion criteria were met by 11,592 patients. During the 2 study periods, 1465 patients underwent surgery, 7083 were seen in clinic via an in-person meeting, and 3044 were assessed via telemedicine.
RESULTS
At 1 year after the COVID-19 outbreak, telemedicine usage was at 81.3% of the initial volume on implementation of shelter-in-place measures. In-person outpatient visits increased 40.2% from the early pandemic volume. Among the 4 neurosurgery divisions, telemedicine usage remained high in tumor and functional neurosurgery, significantly increased in vascular neurosurgery, and decreased in spine neurosurgery.
CONCLUSIONS
Telemedicine use in neurosurgery clinics continues 1 year after the COVID-19 outbreak. Even after the lifting of shelter-in-place measures, many neurosurgeons still use telemedicine, while the operative volume remains stable. Owing to the limited physical examination that can be performed via current telemedicine platforms, telemedicine use in spine neurosurgery is lower than peak use during the early pandemic, while use has remained high among tumor, vascular, and functional neurosurgery.
Identifiants
pubmed: 35306198
pii: S1878-8750(22)00328-X
doi: 10.1016/j.wneu.2022.03.037
pmc: PMC8925084
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e83-e88Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
Telemed J E Health. 2022 Jul;28(7):976-984
pubmed: 34748431
J Neurosurg Sci. 2021 Jan 04;:
pubmed: 33393750
Neurol Clin Pract. 2019 Aug;9(4):314-321
pubmed: 31583186
WMJ. 2021 Oct;120(3):218-221
pubmed: 34710304
Semin Cutan Med Surg. 2013 Dec;32(4):224-9
pubmed: 24800430
Neurosurg Focus. 2020 Dec;49(6):E13
pubmed: 33260126
Mayo Clin Proc Innov Qual Outcomes. 2020 Dec;4(6):736-744
pubmed: 33324948
World Neurosurg. 2020 Aug;140:e387-e394
pubmed: 32512241
World Neurosurg. 2016 May;89:133-8
pubmed: 26852710
World Neurosurg. 2020 Jul;139:549-557
pubmed: 32426065
JAMA Surg. 2021 Jul 1;156(7):620-626
pubmed: 33769434
J Neurooncol. 2021 Jul;153(3):479-485
pubmed: 34115248
Neurosurgery. 2020 Dec 15;88(1):E1-E12
pubmed: 32687191